DK138974B - Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse. - Google Patents

Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.

Info

Publication number
DK138974B
DK138974B DK4375AA DK4375A DK138974B DK 138974 B DK138974 B DK 138974B DK 4375A A DK4375A A DK 4375AA DK 4375 A DK4375 A DK 4375A DK 138974 B DK138974 B DK 138974B
Authority
DK
Denmark
Prior art keywords
parenteral
oral
preparation
topical use
aqueous
Prior art date
Application number
DK4375AA
Other languages
English (en)
Other versions
DK4375A (da
DK138974C (da
Inventor
Hans Peter Ghilardi
Kaya Atasoy
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK4375A publication Critical patent/DK4375A/da
Publication of DK138974B publication Critical patent/DK138974B/da
Application granted granted Critical
Publication of DK138974C publication Critical patent/DK138974C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK4375AA 1974-02-19 1975-01-09 Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse. DK138974B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH227674 1974-02-19

Publications (3)

Publication Number Publication Date
DK4375A DK4375A (da) 1975-10-20
DK138974B true DK138974B (da) 1978-11-27
DK138974C DK138974C (da) 1979-05-07

Family

ID=4229973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK4375AA DK138974B (da) 1974-02-19 1975-01-09 Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.

Country Status (17)

Country Link
US (1) US4020162A (da)
JP (1) JPS50129724A (da)
AT (1) AT336793B (da)
BE (1) BE825656A (da)
CA (1) CA1052270A (da)
DE (1) DE2506579A1 (da)
DK (1) DK138974B (da)
ES (1) ES434805A1 (da)
FR (1) FR2261011B1 (da)
GB (1) GB1494558A (da)
IE (1) IE40663B1 (da)
LU (1) LU71862A1 (da)
MX (1) MX3044E (da)
NL (1) NL7501248A (da)
PH (1) PH11892A (da)
SE (1) SE434457B (da)
ZA (1) ZA751016B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
WO1985004106A1 (fr) * 1984-03-14 1985-09-26 Corbiere Jerome Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues
JPS61130228A (ja) * 1984-11-29 1986-06-18 Sunstar Inc ミノサイクリンを安定に配合した組成物
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US8545831B2 (en) * 2005-05-31 2013-10-01 Warsaw Orthopedic, Inc. Compositions and methods for treating a damaged cardiovascular element
US8945623B2 (en) * 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) * 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
EP2411056A1 (en) * 2009-03-26 2012-02-01 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
US8858924B2 (en) * 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
US8852566B2 (en) 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US9244060B2 (en) * 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US11104054B2 (en) 2016-01-15 2021-08-31 Addex, Inc. High performance cooling system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics

Also Published As

Publication number Publication date
FR2261011A1 (da) 1975-09-12
AU7830775A (en) 1976-08-19
PH11892A (en) 1978-08-29
IE40663B1 (en) 1979-07-18
ES434805A1 (es) 1976-12-01
JPS50129724A (da) 1975-10-14
SE434457B (sv) 1984-07-30
CA1052270A (en) 1979-04-10
ZA751016B (en) 1976-01-28
FR2261011B1 (da) 1978-07-21
ATA119375A (de) 1976-09-15
BE825656A (fr) 1975-08-18
AT336793B (de) 1977-05-25
DK4375A (da) 1975-10-20
NL7501248A (nl) 1975-08-21
LU71862A1 (da) 1975-12-09
IE40663L (en) 1975-08-19
DE2506579A1 (de) 1975-08-21
MX3044E (es) 1980-03-04
GB1494558A (en) 1977-12-07
US4020162A (en) 1977-04-26
DK138974C (da) 1979-05-07

Similar Documents

Publication Publication Date Title
DK138974B (da) Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DK117587B (da) Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.
DK136485B (da) Fremgangsmåde til fremstilling af fysiologisk aktive forbindelser, kaldet ML-236 A, ML-236 B og ML-236 C.
RO69617A (ro) Procedeu pentru prepararea unor 2-tetrahidrofurfuril-6,7-benzomorfani
NL7402008A (nl) Voorbehoedmiddel.
NO802720L (no) Benzofenon-derivater.
SE7504451L (sv) Asymmetriska, halvgenomtrengliga membraner av polybens-1,3-oxazindioner-(2,3).
DK137835B (da) Analogifremgangsmåde til fremstilling af thienothiazinderivater.
DK138321B (da) Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater.
SE7508724L (sv) 2-tiol-4,5-difenyloxazol s-derivat.
NL7506544A (nl) 1,4-benzopyron-6-carbonzuurderivaten.
BE830554A (fr) 9-thia-ou oxothia- et dioxothia- 11,12-seco-prostaglandines
SE406883B (sv) Halslag, speciellt for papper
DK135167B (da) Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater.
DK137449B (da) Fremgangsmåde til fremstilling af N,N-diallyldichloracetamid.
NL7404739A (nl) Instelnok.
DK136652B (da) Fremgangsmåde til fremstilling af thieno-pyridinderivater.
SE7505015L (sv) Forfarande for koncentrering av latexar.
SE7507628L (sv) Slagapparat for festorgan, speciellt tappar.
SE7506804L (sv) 9-tia- eller oxotia- och dioxtia-ll,12-seko-prostaglandiner.
NL7500967A (nl) Dihydroanthraceen derivaten.
FI55374C (fi) Kalander, saerskilt glaettningskalander
NL7416126A (nl) Glucosederivaten.
SE7416378L (sv) Burklock, s.k. twist-off-lock
DK139139B (da) Analogifremgangsmåde til fremstilling af acylamino-quinoxalincarboxamid-1,4-dioxid-derivater.

Legal Events

Date Code Title Description
PBP Patent lapsed
AHB Application shelved due to non-payment